Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Enanta Pharmaceuticals Announces Preliminary Data from AbbVie’s Phase 3b RUBY-I Study in Chronic Hepatitis C Patients with Renal Impairment Presented at The International Liver Congress™ 2015

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced today new preliminary safety and efficacy data from the first cohort of AbbVie’s ongoing, Phase 3b RUBY-I study. RUBY-I is evaluating the regimen of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir […]

Read More »

AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015

VIENNA, April 25, 2015 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study. RUBY-I is evaluating VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) with or without ribavirin (RBV) in treatment-naïve, non-cirrhotic, genotype 1 (GT1) chronic hepatitis C patients with severe […]

Read More »

Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5

VIENNA, Austria–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from two studies evaluating the safety and efficacy of investigational uses of sofosbuvir-based regimens in chronic hepatitis C virus (HCV)-infected patients with genotypes 2, 3, 4 and 5. Results from the BOSON study of Sovaldi® (sofosbuvir 400 mg) in combination with ribavirin (RBV) or with […]

Read More »

New Data Shows Greater In Vitro Potency for VIBATIV(R) (Telavancin) Against Multidrug-Resistant Gram-Positive Bacteria, Including MRSA, Compared to Alternative Antibiotic Treatments

Data Presentations at 2015 ECCMID Conference Highlight Key Findings in Light of the Growing Global Threat of Antibiotic Resistance GEORGE TOWN, GRAND CAYMAN–(Marketwired – Apr 24, 2015) – Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced new positive data from studies of VIBATIV® (telavancin), the Company’s FDA-approved antibiotic. These studies’ results will […]

Read More »

Exercise Can't Save Us: Our Sugar Intake Is The Real Culprit, Say Experts

In a fascinating and scorching editorial in the British Journal of Sports Medicine, three authors argue that the myth that exercise is the key to weight loss – and to health – is erroneous and pervasive, and that it must end. The evidence that diet matters more than exercise is now overwhelming, they write, and […]

Read More »

Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and Bromodomain Protein Inhibitors in Nonclinical Models of Acute Myeloid Leukemia

SALT LAKE CITY–(BUSINESS WIRE)–Tolero Pharmaceuticals, Inc, today announced that it presented nonclinical study results demonstrating profound synergy of lead candidate, alvocidib, and bromo and extra terminal (BET) protein inhibitors in acute myeloid leukemia (AML) models at the 2015 American Association for Cancer Research Annual Meeting in Philadelphia, PA. Alvocidib is a CDK9 inhibitor in clinical development for […]

Read More »

Feeling grateful may improve health for heart failure patients

<span class="articleLocation”>(Reuters Health) – Feeling grateful may help heart failure patients heal both physically and emotionally, say U.S. researchers. Gratitude was linked to better sleep and mood, as well as lower levels of inflammation in people coping with heart failure in a California study. Lead author Paul Mills said in an email that previous studies […]

Read More »

Chinese Scientists Try To Alter Genomes In Human Embryos

Bet you did not know that today is National DNA Day. It is. But before we all begin to party over our biological programming, remember this is also the day when the world is trying to figure out how to respond to a paper from a team of scientists in China stating that they tried […]

Read More »

Mayo Clinic Researchers Identify Methylated DNA Markers That May One Day Lead To Noninvasive Whole Body Cancer Screening

Philadelphia – WEBWIRE – Friday, April 24, 2015 A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers from tumors. The results open the possibility that doctors could one day be able to screen for cancer anywhere in the body with a noninvasive […]

Read More »

World’s first malaria vaccine moves closer to use in Africa

(Reuters) – The world’s first malaria vaccine, made by GlaxoSmithKline, could be approved by international regulators for use in Africa from October after final trial data showed it offered partial protection for up to four years. The shot, called RTS,S and designed for children in Africa, would be the first licensed human vaccine against a […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom